Microbial cell membrane and envelope structure

Microbial cell membranes and envelope structures serve as the primary physical barrier between a pathogen and its environment, providing structural rigidity and regulating the transport of molecules [StatPearls: Antibiotics, 2023]. In bacteria, the cell wall is primarily composed of peptidoglycan, while fungi utilize chitin and glucans; these structures are absent in human cells, making them ideal targets for selective toxicity [PubMed: 18988151]. Many classes of antibiotics, such as beta-lactams and glycopeptides, interfere with the cross-linking of the cell wall, leading to osmotic lysis. Other agents, like polymyxins and polyenes, target the unique lipid compositions of microbial membranes—such as lipopolysaccharides in Gram-negative bacteria or ergosterol in fungi—to induce pore formation and membrane depolarization [PubMed: 27307041]. Because these structures are essential for microbial survival and virulence, they remain a cornerstone of infectious disease therapy, though the emergence of resistance mechanisms like modified target sites or efflux pumps presents a significant clinical challenge [StatPearls: Antifungal Medications, 2023].

Other names

Bacterial cell wallBacterial cell membraneFungal cell wallFungal cell membraneViral envelopePeptidoglycan layerOuter membrane

Drugs targeting these structures act by inhibiting the biosynthesis of essential structural polymers like peptidoglycan (beta-lactams, glycopeptides) or ergosterol (azoles), or by directly disrupting the physical integrity of the lipid bilayer through pore formation or detergent-like effects (polymyxins, polyenes, lipopeptides) [StatPearls: Antibiotics, 2023; PubMed: 27307041].